They found that IKBKE was critically required for tumorigenesis by activating the NF‐κB pathway and that IKBKE expression was drastically upregulated in Kaposi sarcoma‐like lesions and that loss of IKBKE abolished tumor formation. The gene discussed is NFKB1; the disease is Kaposi's sarcoma.